SLXNW Silexion Therapeutics Corp - Warrant

0.0099USD+30.26%Mkt Cap: —P/E: —6d ago

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of sol…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-11.91M USD

Revenue/Share—

Last Price0.0099 USD

Fiscal Year End—

MR Quarter—

Employees13

CountryUS

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.75

EPS (TTM)—

EPS (Forward)—

52W Range

0.00769% of range0.0334

52W High0.0334 USD

52W Low0.0076 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-457.63%

ROA-165.10%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.82M USD

CapEx (TTM)9.00K USD

FCF Margin—

FCF Yield—

Net Debt-819.00K USD

Net Debt/EBITDA0.06

Balance Sheet

Debt/Equity0.78

Current Ratio0.94

Quick Ratio0.56

Book Value/Sh0.0080 USD

Cash/Share0.40 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float5.56M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta-0.30

S&P 52W Chg15.78%

Avg Vol (30d)7.30K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—